Star-net(002396)
Search documents
马斯克量产倒计时!脑机接口进入潜伏期,脑机接口商业化前夜,近期国内布局加速!优质企业详细解读
Xin Lang Cai Jing· 2026-01-27 12:24
Group 1 - Tianqi Co., Ltd. has entered the brain-computer interface (BCI) sector by investing in Suzhou Huahui Chip, focusing on high-density flexible neural electrode technology, achieving animal testing stages, and becoming a key player in domestic BCI hardware localization. The developed flexible neural electrode has 1024 channels, with signal acquisition precision and anti-interference capabilities at an internationally advanced level. The company has also completed biocompatibility surface modification technology to reduce inflammation after electrode implantation, with core patents authorized by the National Intellectual Property Administration [1][2][3] - Innovation Medical, through its subsidiary Boling Brain Machine, is one of the first companies in China to commercialize BCI rehabilitation products. The core product, Cyberlink AC5, was officially launched in October 2025, generating sales revenue of 114,000 yuan in 2025. Another product, Cyberlink AM5, has completed multi-center clinical trials and is progressing through the approval process. The company plans to establish five additional clinical cooperation centers to accelerate the application of BCI technology in treating neurological diseases [4][5][6] - iFlytek is a leading company in the non-invasive BCI field, leveraging its artificial intelligence technology to develop BCI collaborative technology. The company has established long-term partnerships with universities for research and development. Its non-invasive BCI system has been piloted in 120 schools nationwide, improving student attention by 30%. In the medical field, a collaboration with Beijing Tiantan Hospital has achieved a 92% accuracy rate in identifying abnormal brain signals for epilepsy [7][8][9] Group 2 - Jiahe Intelligent focuses on the research and mass production of BCI hardware, particularly EEG acquisition devices and core components, serving both consumer and medical-grade markets. The company has achieved large-scale production of EEG acquisition headphones with a signal recognition accuracy of 92%, primarily used in sleep monitoring and attention training. It plans to expand into overseas BCI hardware markets by 2026 [10][11][12] - Tom Cat is the first company in China to apply BCI technology in consumer scenarios, focusing on interactive games and rehabilitation training products. The company launched a mind-controlled game product in 2025, which quickly gained over 500,000 users. It also collaborates with rehabilitation institutions to develop BCI rehabilitation training systems, showing a 35% average improvement in patient motor function scores [13][14][15] - Hanwei Technology, through its subsidiary Weisheng Technology, is a leading company in the EEG sensor field, with an annual shipment of over 2 million units. The company has developed an epilepsy early warning system with an 88% accuracy rate in clinical tests. It also focuses on flexible pressure sensors for invasive BCI electrodes, addressing industry pain points [16][17][18] Group 3 - StarNet Ruijie leverages its network communication technology to develop low-power, high-stability EEG signal transmission systems and data encryption modules, becoming a core supplier for BCI data links. The developed transmission system supports real-time transmission of 1024-channel EEG signals with a latency of less than 10ms and a stability of 99.9% [19][20][21] - Yijiahe focuses on the integration of BCI and embodied intelligent robots, exploring applications in smart healthcare. The company has signed a strategic cooperation agreement to develop real-time emotional companionship and brain-controlled robots, enhancing the emotional care capabilities of robots [22][23][24] - Lihua Technology is focused on incubating and investing in the BCI sector, successfully incubating three high-tech companies in the field. The company collaborates with the Shenzhen Institute of Advanced Technology to provide comprehensive services for incubated companies, addressing development pain points [25][26][27] Group 4 - Sanbo Neurosurgery is a leading private hospital in the neurosurgery field, focusing on the clinical application and research of BCI. The company has successfully conducted an interventional BCI surgery, accumulating valuable experience for clinical applications. It is also recruiting participants for ongoing clinical trials [28][29][30] - Shiyun Circuit is a core enterprise in the PCB field, providing customized PCB products for BCI devices. The company focuses on high-density, flexible PCB designs, achieving low signal loss rates below 2% [31][32][33] - Meihua Medical is a leading supplier of core components for BCI, having entered the core supply chain for invasive BCI products. The company has developed components that have passed biocompatibility tests, ensuring long-term stability and safety for implanted devices [34][35][36]
星网锐捷股价连续3天上涨累计涨幅6.42%,嘉实基金旗下1只基金持1.57万股,浮盈赚取2.84万元
Xin Lang Cai Jing· 2026-01-27 07:32
Group 1 - The stock price of StarNet Ruijie has increased by 6.42% over the last three days, currently trading at 30.01 CNY per share with a market capitalization of 17.577 billion CNY [1] - StarNet Ruijie, established on November 11, 1996, and listed on June 23, 2010, operates in various sectors including network communication, cloud terminal and payment, digital entertainment, integrated communication, vehicle networking, and wireless communication systems [1] - The company's revenue composition is as follows: enterprise-level network equipment 72.69%, communication products 13.69%, others 10.02%, and network terminals 3.60% [1] Group 2 - According to data, the Jiashi New Additive Mixed A Fund (005088) holds 15,700 shares of StarNet Ruijie, representing 1.05% of the fund's net value, making it the third-largest holding [2] - The fund has generated a floating profit of approximately 157 CNY today and 28,400 CNY during the three-day increase [2] - The Jiashi New Additive Mixed A Fund was established on September 28, 2017, with a current scale of 44.4664 million CNY and has achieved a year-to-date return of 10.85% [2]
星网锐捷涨2.00%,成交额2.43亿元,主力资金净流入134.86万元
Xin Lang Zheng Quan· 2026-01-21 02:46
Group 1 - The core viewpoint of the news is that Xingwang Ruijie has experienced fluctuations in stock price and trading volume, with a current market capitalization of 16.71 billion yuan and a year-to-date stock price decline of 5.84% [1] - As of January 21, the stock price increased by 2.00% to 28.53 yuan per share, with a trading volume of 243 million yuan and a turnover rate of 1.47% [1] - The company has a diverse business portfolio, including enterprise-level network equipment (72.69% of revenue), communication products (13.69%), and other services [1] Group 2 - As of September 30, the number of shareholders decreased by 8.99% to 49,000, while the average circulating shares per person increased by 9.88% to 11,913 shares [2] - For the period from January to September 2025, the company achieved a revenue of 14.168 billion yuan, representing a year-on-year growth of 19.20%, and a net profit attributable to shareholders of 344 million yuan, up 31.06% [2] - The company has distributed a total of 1.145 billion yuan in dividends since its A-share listing, with 353 million yuan distributed in the last three years [3] Group 3 - As of September 30, 2025, the second-largest circulating shareholder is Hong Kong Central Clearing Limited, holding 70.764 million shares, an increase of 25.151 million shares from the previous period [3] - Other notable shareholders include E Fund's various funds, with increases in holdings, while the Southern CSI 1000 ETF saw a slight decrease in shares [3]
今日,多个重磅!融资保证金比例新规将实施;2025年国民经济运行数据将公布……盘前重要消息一览
Zheng Quan Shi Bao· 2026-01-19 00:44
Group 1 - New stock subscriptions: Agricultural University Technology subscription code 920159, issue price 25 yuan/share, subscription limit 720,000 shares. Zhenstone Co. subscription code 780112, issue price 11.18 yuan/share, subscription limit 54,500 shares [6] - The China Securities Regulatory Commission (CSRC) held a system work meeting on January 15, 2026, emphasizing the need to maintain market stability and enhance monitoring and regulation to prevent market volatility [7] - The CSRC is investigating Rongbai Technology for misleading statements regarding a major contract, which the company estimated at a total of 120 billion yuan with CATL [9] Group 2 - Minexplosion Optoelectronics plans to acquire Xiamen Zhizhi Precision and Jiangxi Maida, both focusing on core consumables in PCB manufacturing [10] - Yanjing Co. intends to purchase 98.54% equity of Yongqiang Technology, expanding its business into high-end electronic interconnection materials for integrated circuits [11] - Qizhong Technology plans to invest 50 million yuan in a stake in He Xin Integrated, a company in the advanced packaging and testing field [12] Group 3 - Tianyuan Intelligent's actual controller and chairman, Wu Yizhong, has been detained [14] - Tian Tie Technology's actual controller, Xu Jiding, has had his compulsory measures changed to bail pending trial [15] - Guolian Minsheng expects a net profit increase of approximately 406% year-on-year for 2025 [16] Group 4 - Oke Yi anticipates a net profit increase of 67.53% to 91.96% year-on-year for 2025 [17] - I Love Home expects a net profit increase of 40.78% to 56.42% year-on-year for 2025 [17] - Longi Green Energy expects a net profit loss of 6 billion to 6.5 billion yuan for 2025 [17]
陆家嘴财经早餐2026年1月17日星期六
Wind万得· 2026-01-16 23:51
Group 1 - The China Securities Regulatory Commission (CSRC) emphasized maintaining market stability and enhancing monitoring and regulation to prevent excessive speculation and market manipulation [3] - Canada and China reached a consensus on deepening economic and trade cooperation, signing the "China-Canada Economic and Trade Cooperation Roadmap," which includes an annual quota of 49,000 electric vehicles from China with a 6.1% most-favored-nation tariff [3] Group 2 - The State Council of China is focusing on boosting consumption and has outlined measures to clear overdue payments to businesses and ensure wage payments to migrant workers [4] - The Ministry of Commerce announced stronger support for green and smart product consumption through a recycling program for consumer goods [4] Group 3 - The State-owned Assets Supervision and Administration Commission (SASAC) is working on optimizing the layout and structure of state-owned enterprises, focusing on enhancing core business strengths [5] - The Market Supervision Administration has introduced new guidelines for recognizing illegal gains in market regulation, effective from March 20 [5] Group 4 - The A-share market experienced fluctuations, with the Shanghai Composite Index closing at 4,101.91 points, down 0.26%, while the Shenzhen Component Index and the ChiNext Index also saw slight declines [6] - The Hong Kong stock market showed mixed results, with the Hang Seng Index closing down 0.29% but showing a weekly gain of 2.34% [7] Group 5 - The Ministry of Housing and Urban-Rural Development highlighted significant investment opportunities in urban renewal projects during the 14th Five-Year Plan period [11] - The Ministry of Finance extended tax incentives for public rental housing, exempting certain taxes to promote construction [11] Group 6 - The China Automotive Power Battery Industry Innovation Alliance reported a 60.1% year-on-year increase in the cumulative production of power and energy storage batteries in 2025 [12] - The China Securities Association announced new rules allowing certain individual investors to redeem public pension fund shares early under specific conditions [12] Group 7 - The U.S. Federal Reserve officials indicated that current monetary policy remains moderately restrictive, with potential adjustments depending on labor market conditions [15][16] - The U.S. Senate approved funding for federal research institutions, rejecting previous budget cuts proposed by the Trump administration [16] Group 8 - The Chinese bond market showed signs of warming, with yields generally declining and the central bank conducting a net injection of liquidity [20] - Barclays analysts forecast a total issuance of U.S. corporate bonds to reach $2.46 trillion in 2026, marking an 11.8% increase year-on-year [20]
星网锐捷:参股公司睿云联1月16日申请港股上市
Sou Hu Cai Jing· 2026-01-16 13:40
Core Viewpoint - Xingwang Ruijie announced that its associate company, Xiamen Ruiyunlian Innovation Technology Co., Ltd., has submitted an application for an initial public offering (IPO) on the Hong Kong Stock Exchange, which has been accepted [1] Group 1: Company Overview - Ruiyunlian is a provider of intelligent intercom solutions, involved in the development, manufacturing, and sales of smart intercom, access control, and smart home products [1] - The company also offers cloud services to global customers [1] Group 2: Shareholding Information - As of the announcement date, Xingwang Ruijie holds a 37.9147% stake in Ruiyunlian [1]
星网锐捷(002396.SZ):参股公司睿云联向香港联交所递交上市申请
Ge Long Hui A P P· 2026-01-16 13:15
Core Viewpoint - Xingwang Ruijie (002396.SZ) announced that its associate company, Xiamen Ruiyun Lianxin Technology Co., Ltd. (referred to as "Ruiyun Lian"), has submitted an application for an initial public offering (IPO) of overseas listed shares (H-shares) to the Hong Kong Stock Exchange on January 16, 2026 [1] Group 1 - Ruiyun Lian is a provider of intelligent intercom solutions, specializing in the development, manufacturing, and sales of smart intercom, access control, and smart home products, as well as offering cloud services to global customers [1] - As of the date of the announcement, the company holds a 37.9147% stake in Ruiyun Lian [1]
星网锐捷(002396) - 关于参股公司向香港联交所递交上市申请的公告
2026-01-16 12:45
关于参股公司向香港联交所递交上市申请的公告 证券代码:002396 证券简称:星网锐捷 公告编号:临 2026-01 福建星网锐捷通讯股份有限公司 - 1 - 睿云联本次发行H股及上市尚需取得中国证券监督管理委员会、香港证券及 期货事务监察委员会和香港联交所等相关监管机构、证券交易所的批准、核准或 备案,该事项仍存在不确定性。公司将根据该事项的进展情况及时履行信息披露 义务,敬请广大投资者谨慎决策,注意投资风险。 特此公告。 福建星网锐捷通讯股份有限公司 董 事 会 2026 年 1 月 16 日 本公司及董事会全体成员保证公告内容真实、准确和完整,不存在虚假记载、误导性陈 述或者重大遗漏。 福建星网锐捷通讯股份有限公司(以下简称:"公司"、"星网锐捷")从参股 公司厦门睿云联创新科技股份有限公司(以下简称:"睿云联")处获悉,其已于 2026年1月16日向香港联合交易所有限公司(以下简称"香港联交所")递交了首 次公开发行境外上市股份(H股)并在香港联交所主板上市(以下简称"本次发 行")的申请,并于同日在香港联交所网站刊登了本次发行的申请资料。 睿云联是一家开发、制造及销售智能对讲、门禁及智能家居产品,并 ...
星网锐捷:参股公司睿云联向香港联交所递交上市申请
Xin Lang Cai Jing· 2026-01-16 12:40
Core Viewpoint - The company has announced that its associate, Xiamen Ruiyun Lianxin Technology Co., Ltd., has submitted an application for an initial public offering (IPO) to list overseas shares on the Hong Kong Stock Exchange on January 16, 2026 [1] Group 1 - Xiamen Ruiyun Lianxin is a provider of intelligent intercom solutions, specializing in the development, manufacturing, and sales of smart intercom, access control, and smart home products, as well as offering cloud services to global customers [1] - As of the date of the announcement, the company holds a 37.9147% stake in Ruiyun Lian [1]
福州高新区点燃科创引擎 两大前沿赛道入选国家重点培育赛道
Xin Hua Wang· 2026-01-16 01:49
Group 1: Industrial Internet Sector - The Fuzhou High-tech Zone has been recognized as a key cultivation area for the "Industrial Internet" and "High-end Medical Devices" sectors, being the only selected park in Fujian Province [1] - The Industrial Internet sector in Fuzhou High-tech Zone has established a complete industrial ecosystem, generating annual revenue exceeding 10 billion [2][5] - The sector enables smart and collaborative production processes through the interconnection of industrial equipment and data sharing, serving as a crucial tool for the digital transformation of manufacturing [2] Group 2: High-end Medical Devices Sector - The high-end medical devices sector in Fuzhou High-tech Zone has accumulated over 400 effective invention patents, indicating strong innovation capabilities [6][7] - Companies like Wintone (Fujian) Medical Science and Technology Co., Ltd. are developing advanced medical imaging equipment, contributing to the localization of medical imaging device production in Fujian Province [6] - The zone has implemented supportive measures for the biopharmaceutical industry, including subsidies for companies achieving medical device registration, fostering a complete incubation system for related enterprises [7]